Free Content Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression

Authors: Vreeburg, E. M.1; Levi, M.; Rauws, E. A. J.1; Deventer, S. J. H. V.1; Snel, P.2; Bartelsman, J. W. F. M.1; Ten Cate, J. W.3; Tytgat, G. N. J.1

Source: Alimentary Pharmacology & Therapeutics, Volume 15, Number 5, May 2001 , pp. 639-646(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: 

The high mortality rate in patients with upper gastrointestinal bleeding appears to be particularly related to re-bleeding. The haemostatic mechanisms that may influence the re-bleeding of ulcers are largely unknown. Aim: 

We studied and analysed fibrinolytic activity in bleeding ulcer patients and the effect of acid suppression on this activity. Methods: 

Fibrinolytic activity was analysed in mucosal biopsies from 29 bleeding gastroduodenal ulcer patients and six controls. We analysed levels of D-Dimer, fibrin plate lysis area, plasminogen activator activity, plasminogen activator inhibitor activity, and plasmin antiplasmin complexes. Results: 

Significantly more fibrinolytic activity was detected in biopsies from patients with bleeding ulcers compared to controls. Moreover, in patients with endoscopic stigmata of recent haemorrhage, mucosal fibrinolytic activity was higher compared to patients without stigmata of recent haemorrhage. In mucosal biopsies of patients that had used acid suppression before admission, a decreased fibrinolytic activity was found compared to patients without such therapy. This effect of acid suppression on fibrinolytic activity was confirmed in nine patients before and after a 24-h ranitidine infusion. Conclusions: 

Fibrinolytic activity is enhanced in patients with bleeding gastroduodenal ulcers. Acid suppressive therapy decreases this increased activity, which may be one of the mechanisms explaining the potential beneficial effect of this therapy.

Document Type: Research article

DOI: 10.1046/j.1365-2036.2001.00978.x

Affiliations: 1: Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, the Netherlands 2: Department of Gastroenterology and Hepatology, Slotervaarthospital, Amsterdam, the Netherlands 3: Centre for Hemostasis, Thrombosis, Artherosclerosis and Inflammation Research, Academic Medical Centre, Amsterdam, the Netherlands

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A